Randomized Controlled Trial of Endoscopic Ultrasound‐Guided Liver Biopsy Versus Percutaneous Liver Biopsy for Obtaining Histologically Adequate Specimens
Authors:
Top Cited Papers
- 17 May 2026
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
Abstract
Aim: To compare endoscopic ultrasound‐guided liver biopsy (EUS‐LB) with percutaneous liver biopsy (P‐LB) in terms of histological adequacy, safety, and patient‐reported pain in parenchymal liver disease. Methods: In this single‐center randomized controlled trial, 80 patients were assigned to either EUS‐LB ( n = 41) or P‐LB ( n = 39). The primary endpoint was histological adequacy, defined as total specimen length (TSL) ≥ 15 mm and ≥ 6 complete portal tracts (CPTs). The main secondary endpoints were the definitive histological diagnostic rate, specimen characteristics (CPTs, TSL, and longest specimen length), patient‐reported pain, and procedure‐related adverse events (AEs). EUS‐LB employed a 19‐gauge Franseen‐tip needle with wet suction under conscious sedation, whereas P‐LB used a 16‐gauge Tru‐Cut needle under local anesthesia. Results: Histological adequacy based on predefined histologic criteria was achieved more frequently with EUS‐LB than with P‐LB (70.7% vs. 10.3%; difference, 60.4%; 95% CI 43.5–77.3). The definitive histological diagnostic rates were similar (92.7% vs. 97.4%). The median TSL was longer with EUS‐LB (20.0 vs. 12.8 mm), whereas ≥ 6 CPTs were more common with P‐LB (97.4% vs. 80.5%). AEs occurred in 2.4% versus 25.6%, driven in the P‐LB arm by procedural stress–related hemodynamic responses (transient grade III hypertension); patient‐reported pain favored EUS‐LB (no pain during the procedure, 95.1% vs. 30.8%). No serious AEs or bleeding events occurred, and none required prolonged hospitalization. Conclusions: EUS‐LB met the noninferiority criterion for histologic adequacy and achieved a diagnostic performance comparable to that of P‐LB with lower patient‐reported pain. EUS‐LB may be a reasonable alternative when endoscopic expertise and sedation are available.Keywords
This publication has 21 references indexed in Scilit:
- Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020Journal of Gastroenterology, 2021
- Single-pass 1-needle actuation versus single-pass 3-needle actuation technique for EUS-guided liver biopsy sampling: a randomized prospective trial (with video)Gastrointestinal Endoscopy, 2021
- Comparison of Two Specialized Histology Needles for Endoscopic Ultrasound (EUS)-Guided Liver Biopsy: A Pilot StudyDigestive Diseases and Sciences, 2020
- A Comparative Study of 22G versus 19G Needles for EUS-Guided Biopsies for Parenchymal Liver Disease: Are Thinner Needles Better?Digestive Diseases and Sciences, 2020
- EUS-guided fine-needle core liver biopsy sampling using a novel 19-gauge needle with modified 1-pass, 1 actuation wet suction techniqueGastrointestinal Endoscopy, 2018
- EUS-guided liver biopsy provides diagnostic samples comparable with those via the percutaneous or transjugular routeGastrointestinal Endoscopy, 2016
- Histological adequacy of EUS-guided liver biopsy when using a 19-gauge non–Tru-Cut FNA needleGastrointestinal Endoscopy, 2014
- High yield of same-session EUS-guided liver biopsy by 19-gauge FNA needle in patients undergoing EUS to exclude biliary obstructionGastrointestinal Endoscopy, 2012
- Liver biopsy†Hepatology, 2009
- Adequacy of Endoscopic Ultrasound Core Needle Biopsy Specimen of Nonmalignant Hepatic Parenchymal DiseaseClinical Gastroenterology and Hepatology, 2008